The ºÚÁϳԹÏÍø Health Genomics Strategy articulates a shared vision for clinical genomics in ºÚÁϳԹÏÍø, promoting collaboration to avoid fragmentation and duplication of resources.
Genomic technology can provide greater accuracy in determining disease risk, assessing diagnosis and prognosis, and informing the selection of therapeutic options for care. It is already being applied in a range of clinical contexts in ºÚÁϳԹÏÍø, raising strategic challenges and choices to be addressed if the promise of precision medicine and personalised care are to be fully realised.
The strategy makes recommendations and describes pathways to implementation. To achieve this, ºÚÁϳԹÏÍø will build on current partnerships with service providers, clinicians, researchers, industry and consumers. Working together, we can achieve the ºÚÁϳԹÏÍø vision for clinical genomics.
The ºÚÁϳԹÏÍø Health Genomics Strategy Implementation Plan 2021-25 has been developed with consumers, clinicians, researchers and health managers using a co-design approach.
This plan builds on the significant achievements in delivering foundational initiatives described in the ºÚÁϳԹÏÍø Health Genomics Strategy Implementation Plan 2018-20.
Over the next five years and beyond, ºÚÁϳԹÏÍø will continue to work towards realising the vision of the ºÚÁϳԹÏÍø Health Genomics Strategy, through delivering key initiatives in clinical genomics focused to enhance disease management and prevention across the ºÚÁϳԹÏÍø Health system.
Translating Genomics Research into Clinical Practice: A ºÚÁϳԹÏÍø Health framework for researchers and clinicians is a priority initiative articulated within the ºÚÁϳԹÏÍø Health Genomics Strategy Implementation Plan 2021-25.
This framework aims to address the gap between genomics research and clinical practice and enable the appropriate and consistent translation of genomics for the benefit of the ºÚÁϳԹÏÍø population.